期刊文献+

miR-375在AGEs介导糖尿病血管损伤细胞中的生物学功能 被引量:4

The Biological Function of miR-375 in Vascular Cells Injury Induced by AGEs-mediated Diabetes
原文传递
导出
摘要 目的:探讨miR-375在血管损伤细胞中的表达及生物学功能。方法:利用基因克隆技术构建miR-375表达载体;然后将miR-375表达质粒转染至血管损伤细胞中,同时分别设立Huvec12对照组,血管损伤细胞组,血管损伤抑制组,Huvec12转染miR-375组。24h后收集细胞,在mRNA和蛋白水平检测Mtpn、NFκB、profilin1、sICAM1的表达,经荧光染色观察细胞F-actin的变化,再用流式细胞仪检测细胞凋亡。结果:血管损伤细胞中过表达miR-375后,在mRNA和蛋白水平靶基因Mtpn下降,NFκB的表达活性下降,使糖尿病血管病变的标志profilin1下调;F-actin表达恢复;细胞粘附因子(sICAM1)表达下降,细胞凋亡减少。结论:初步证明miR-375可以抑制AGEs介导的糖尿病血管细胞损伤的发生,可能成为糖尿病血管损伤并发症基因治疗的靶点。 Objective: To investigate the expression and biological function of miR-375 in injured vascular cells. Methods: Cloning technology was used to construct miR-375 expression vector and subsequently mir-375 expression plasmid was transfected into injured vascular cells. Meanwhile, we set for further study: Huvec12 as control, injured vascular cells, vascular cells after injury inhibition and cells with miR-375 overexpression. Cells were harvested 24 hours after treatments. The expression of Mtpn, NFκB, profilin1 and sICAM1 were measured in both mRNA and protein level. F-actin was examined via fluorescence staining. Cell apoptosis was assessed by flow cytometry. Results: In injured vascular cells with miR-375 overexpression, the mRNA and protein expression of targeted gene Mtpn declined. It was also observed the reduction of NFκB activity, downregulation of the diabetic vascular injury marker profilin1, restoration of F-actin expression, a decrease of sICAM1 expression and reduced cell apoptosis. Conclusions: miR-375 may inhibit the injuries of vascular cells caused by AGEs-mediated diabetes and may become a new target for gene therapy to treat vascular complications caused by diabetes.
出处 《现代生物医学进展》 CAS 2014年第13期2441-2445,共5页 Progress in Modern Biomedicine
关键词 miR-375 AGES 转染 血管损伤细胞 miR-375 AGEs Transfection Injured vascular cells
  • 相关文献

参考文献2

二级参考文献18

  • 1郭晓华,黄巧冰,陈波,王述昀,侯凡凡,富宁.晚期糖化终产物诱导内皮细胞通透性增高[J].生理学报,2005,57(2):205-210. 被引量:13
  • 2韩雅玲,于海波,闫承慧,孟子敏,张效林,康建,李少华,王士雯.血清反应因子参与RhoA诱导的人血管内皮细胞肌动蛋白骨架重构[J].生理学报,2005,57(3):295-302. 被引量:8
  • 3李强,郭晓华,朱艳军,陈波,邓建新,黄绪亮,黄巧冰.晚期糖基化终产物诱导内皮细胞紧密连接改变及其机制[J].中国动脉硬化杂志,2006,14(6):499-502. 被引量:9
  • 4Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 2003; 39 (4-5): 187-199.
  • 5Sakabe M, lkeda K, Nakatani K, Kawada N, Imanaka-Yoshida K, Yoshida T, Yamagishi T, Nakajima Y. Rho kinases regulate endothelial invasion and migration during valvuloseptal en- docardial cushion tissue formation. Dev Dyn 2006; 235(1): 94- 104.
  • 6Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001; 91 (4): 1487- 1500.
  • 7Hou FF, Boyce J, Chertow GM, Kay J, Owen WF Jr. Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin. J Am Soc Nephrol 1998; 9 (2): 277-283.
  • 8Iwasaki K, Hayashi K, Fujioka T, Sobue K. Rho/Rho-associated kinase signal regulates myogenic differentiation via myocardin-related transcription factor-A/Smad-dependent transcription of the Id3 gene. J Biol Chem 2008; 283(30): 21230-21241.
  • 9Leto G, Pricci F, Amadio L, Iacobini C, Cordone S, Diaz- Horta O, Romeo G, Barsotti P, Rotella CM, di Mario U, Pugliese G. Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation. Diabetes Metab Res Rev 2001; 17(6): 448-458.
  • 10Enomoto M, Adachi H, Yamagishi S, Takeuchi M, Furuki K, Hino A, Hiratsuka A, Takajo Y, Imaizumi T. Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans. Metabolism 2006; 55 (7): 912-917.

共引文献67

同被引文献30

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部